Cover Kidney News
Volume/Issue:
Volume 11: Issue 5
Page:
14
Publication Date:
01 May 2019
Online Publication Date:
06 May 2019
Figure 1.
  • 1.

    Gupta N, Wish JB. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD. Am J Kidney Dis 2017; 69:815–826.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Kaplan JM, Sharma N, Dikdan S. Hypoxia-inducible factor and its role in the management of anemia in chronic kidney disease. Int J Mol Sci 2018; 19:389.

  • 3.

    Locatelli F, et al.. Targeting hypoxia-inducible factors for the treatment of anemia in chronic kidney disease patients. Am J Nephrol 2017; 45:187–199.

Editorial Type:
Features

HIF Stabilizers: Will They Have a Place?

Jay Wish Jay Wish, MD, is medical director of the outpatient dialysis unit at Indiana University Hospital and professor of clinical medicine at Indiana University School of Medicine in Indianapolis, IN.

Search for other papers by Jay Wish in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 11: Issue 5
Publication Date:
01 May 2019
Page:
14
Restricted access
Save